Cumulative exposure to metabolic syndrome increases thyroid cancer risk in young adults: a population-based cohort study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: A re-increasing trend of thyroid cancer since 2015 has been observed despite a similar examination rate, and the incidence of thyroid cancer among young adults continues to rise. Methods: This study used data from the Korean National Health Insurance Service. Individuals 20–39 years of age who underwent ≥ 4 health checkups from 2009–2013 were enrolled and followed throughout 2019. To quantify the metabolic burden, groups were divided by the number of diagnoses of metabolic syndrome across four consecutive health examinations. Results: Among the study population (n = 1,204,646), 5,929 (0.5%) were diagnosed with thyroid cancer during a follow- up period of 5 years. The hazard ratio (95% confidence interval) values of thyroid cancer occurrence according to the number (1–4) of diagnoses of metabolic syndrome across the four health examinations compared to the group without metabolic syndrome were significantly greater, as follows: 1.12 (1.02–1.23), 1.25 (1.10–1.42), 1.33 (1.15–1.55), and 1.48 (1.25–1.75) (p for trend < 0.01), respectively. Each component of metabolic syndrome showed a significant increase in hazard ratio according to the number of diagnoses except for impaired fasting glucose criteria. Conclusions: Cumulative exposure to metabolic syndrome was associated with thyroid cancer risk in young adults.
Abstract
Background/Aims: A re-increasing trend of thyroid cancer since 2015 has been observed despite a similar examination rate, and the incidence of thyroid cancer among young adults continues to rise. Methods: This study used data from the Korean National Health Insurance Service. Individuals 20–39 years of age who underwent ≥ 4 health checkups from 2009–2013 were enrolled and followed throughout 2019. To quantify the metabolic burden, groups were divided by the number of diagnoses of metabolic syndrome across four consecutive health examinations. Results: Among the study population (n = 1,204,646), 5,929 (0.5%) were diagnosed with thyroid cancer during a follow- up period of 5 years. The hazard ratio (95% confidence interval) values of thyroid cancer occurrence according to the number (1–4) of diagnoses of metabolic syndrome across the four health examinations compared to the group without metabolic syndrome were significantly greater, as follows: 1.12 (1.02–1.23), 1.25 (1.10–1.42), 1.33 (1.15–1.55), and 1.48 (1.25–1.75) (p for trend < 0.01), respectively. Each component of metabolic syndrome showed a significant increase in hazard ratio according to the number of diagnoses except for impaired fasting glucose criteria. Conclusions: Cumulative exposure to metabolic syndrome was associated with thyroid cancer risk in young adults.
참고문헌 (35)
- Ahn HS, "Korea’s thyroid-cancer"epidemic"--screening and overdiagnosis", N Engl J Med, 371, pp.1765~1767 (2014)
- Welch HG, "Saving thyroids-Overtreatment of small papillary cancers", N Engl J Med, 379, pp.310~312 (2018)
- 정찬권, "Re-Increasing Trends in Thyroid Cancer Incidence after a Short Period of Decrease in Korea: Reigniting the Debate on Ultrasound Screening", Endocrinology and Metabolism, 37(5), pp.816~818 (2022), 대한내분비학회[DOI]
- 최윤미, "Recent Changes in the Incidence of Thyroid Cancer in Korea between 2005 and 2018: Analysis of Korean National Data", Endocrinology and Metabolism, 37(5), pp.791~799 (2022), 대한내분비학회[DOI]
- Marcello MA, "Obesity and thyroid cancer", Endocr Relat Cancer, 21, pp.T255~271 (2014)
- Park J, "Trends in childhood thyroid cancer incidence in Korea and its potential risk factors", Front Endocrinol(Lausanne), 12, pp.681148~ (2021)
- Schmid D, "Adiposity and risk of thyroid cancer : a systematic review and meta-analysis", Obes Rev, 16, pp.1042~1054 (2015)
- Kwon H, "Weight change is significantly associated with risk of thyroid cancer : a nationwide population-based cohort study", Sci Rep, 9, pp.1546~ (2019)
- Park JH, "Metabolic syndrome and the risk of thyroid cancer : a nationwide population-based cohort study", Thyroid, 30, pp.1496~1504 (2020)
- Nguyen DN, "Association of metabolic health and central obesity with the risk of thyroid cancer : data from the Korean genome and epidemiology study", Cancer Epidemiol Biomarkers Prev, 31, pp.543~553 (2022)
- Kharazmi E, "Familial risk of early and late onset cancer : nationwide prospective cohort study", BMJ, 345, pp.e8076~ (2012)
- Ugai T, "Is early-onset cancer an emerging global epidemic? Current evidence and future implications", Nat Rev Clin Oncol, 19, pp.656~673 (2022)
- 김미경, "Current Trends of Big Data Research Using the Korean National Health Information Database", Diabetes and Metabolism Journal, 46(4), pp.552~563 (2022), 대한당뇨병학회[DOI]
- 오상우, "Obesity and Metabolic Syndrome in Korea", Diabetes and Metabolism Journal, 35(6), pp.561~566 (2011), 대한당뇨병학회
- Esposito K, "Metabolic syndrome and risk of cancer : a systematic review and meta-analysis", Diabetes Care, 35, pp.2402~2411 (2012)
- Ayturk S, "Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area", Eur J Endocrinol, 161, pp.599~605 (2009)
- Anil C, "Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area", Metabolism, 62, pp.970~975 (2013)
- Pitoia F, "Insulin resistance is another factor that increases the risk of recurrence in patients with thyroid cancer", Endocrine, 48, pp.894~901 (2015)
- Bae MJ, "High prevalence of papillary thyroid cancer in Korean women with insulin resistance", Head Neck, 38, pp.66~71 (2016)
- Aschebrook-Kilfoy B, "Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study", Thyroid, 21, pp.957~963 (2011)
- Cho YY, "Protective effect of metformin against thyroid cancer development : a population-based study in Korea", Thyroid, 28, pp.864~870 (2018)
- Jun-Qing Jin, "Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway", Endocrinology and Metabolism, 36(5), pp.1095~1110 (2021), 대한내분비학회[DOI]
- Jafri H, "Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy", J Am Coll Cardiol, 55, pp.2846~2854 (2010)
- Ahn J, "Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer", Cancer Epidemiol Biomarkers Prev, 18, pp.2814~2821 (2009)
- Vekic J, "Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects", Eur J Clin Invest, 37, pp.715~723 (2007)
- Pedersen KM, "Low high-density lipoprotein and increased risk of several cancers : 2 population-based cohort studies including 116, 728 individuals", J Hematol Oncol, 13, pp.129~ (2020)
- Morin EE, "HDL in endocrine carcinomas:biomarker, drug carrier, and potential therapeutic", Front Endocrinol(Lausanne), 9, pp.715~ (2018)
- Shin A, "Body mass index and thyroid cancer risk : a pooled analysis of half a million men and women in the Asia cohort consortium", Thyroid, 32, pp.306~314 (2022)
- Cypess AM, "Reassessing human adipose tissue", N Engl J Med, 386, pp.768~779 (2022)
- Zimmet P, "The metabolic syndrome : a global public health problem and a new definition", J Atheroscler Thromb, 12, pp.295~300 (2005)
- Park JH, "Thyroid cancer in patients with metabolic syndrome or its components: a nationwide population-based cohort study", Cancers(Basel), 14, pp.4106~ (2022)
- Sugitani I, "Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma : consensus statements from the Japan association of endocrine surgery task force on management for papillary thyroid microcarcinoma", Thyroid, 31, pp.183~192 (2021)
- Williams D, "Radiation carcinogenesis : lessons from Chernobyl", Oncogene, 27(Suppl 2), pp.S9~S18 (2008)
- Kruger E, "Thyroid carcinoma: a review for 25 years of environmental risk factors studies", Cancers(Basel), 14, pp.6172~ (2022)
- 양예슬, "Obesity Fact Sheet in Korea, 2021: Trends in Obesity Prevalence and Obesity-Related Comorbidity Incidence Stratified by Age from 2009 to 2019", Journal of Obesity & Metabolic Syndrome, 31(2), pp.169~177 (2022), 대한비만학회